Comparative Pharmacology
Head-to-head clinical analysis: PROMETHAZINE versus PSEUDOEPHEDRINE HYDROCHLORIDE AND TRIPROLIDINE HYDROCHLORIDE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PROMETHAZINE versus PSEUDOEPHEDRINE HYDROCHLORIDE AND TRIPROLIDINE HYDROCHLORIDE.
PROMETHAZINE vs PSEUDOEPHEDRINE HYDROCHLORIDE AND TRIPROLIDINE HYDROCHLORIDE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Promethazine is a phenothiazine derivative that acts as a potent histamine H1 receptor antagonist, thereby blocking the effects of histamine. It also has central anticholinergic, antiemetic, and sedative properties, likely mediated through antagonism at muscarinic, dopamine D2, and serotonin receptors in the brain.
Pseudoephedrine is a sympathomimetic amine that acts as an indirect agonist at alpha- and beta-adrenergic receptors, causing vasoconstriction in the nasal mucosa and bronchodilation. Triprolidine is a first-generation antihistamine that competitively antagonizes histamine at H1 receptors, reducing allergic symptoms such as sneezing, rhinorrhea, and pruritus.
12.5-25 mg IM or IV every 4-6 hours; also 25 mg PO or PR every 6-8 hours. Maximum 100 mg/day.
1 tablet (pseudoephedrine HCl 60 mg + triprolidine HCl 2.5 mg) orally every 4-6 hours, not to exceed 4 doses in 24 hours.
None Documented
None Documented
Clinical Note
moderatePromethazine + Risedronic acid
"Promethazine can cause an increase in the absorption of Risedronic acid resulting in an increased serum concentration and potentially a worsening of adverse effects."
Clinical Note
moderatePromethazine + Methylphenidate
"Promethazine can cause an increase in the absorption of Methylphenidate resulting in an increased serum concentration and potentially a worsening of adverse effects."
Clinical Note
moderatePromethazine + Artesunate
"The serum concentration of Artesunate can be increased when it is combined with Promethazine."
Clinical Note
moderateTerminal elimination half-life 9-16 hours; may be prolonged in hepatic impairment.
Pseudoephedrine: 5-8 hours (pH-dependent; alkaline urine increases half-life); Triprolidine: approximately 2-4 hours. Combined product: pseudoephedrine half-life is clinically relevant for dosing frequency.
Renal (70-80% as metabolites, <1% unchanged); biliary/fecal minor.
Pseudoephedrine: ~70-90% renal as unchanged drug, minor hepatic metabolism (N-demethylation); Triprolidine: extensively hepatic metabolized, renal elimination of metabolites and unchanged drug (<5% unchanged), total excretion primarily renal and biliary.
Category A/B
Category A/B
Antihistamine / Antiemetic
Antihistamine
Promethazine + Clotrimazole
"The metabolism of Clotrimazole can be decreased when combined with Promethazine."